William Blair initiates coverage of Immunome with outperform rating
IMNM•William Blair initiated coverage of Immunome with an outperform rating.
Related News
Markets may be nearing a tipping point
SPY•
Comstock Resources target price cut to $17 from $20
CRK•
MasTec publishes update to financial calendar
MTZ•
Cytokinetics initiated with outperform rating by William Blair
CYTK•
Fractyl Health's Revita meets six-month weight-maintenance endpoint in pivotal trial
GUTS•